Reference
Prieto SK, et al. Transient hyperthyroidism caused by pemprolizumab: A case report. Journal of Investigative Medicine 66: 406 abstr. 132, No. 2, 22 Feb 2018. Available from: URL: http://doi.org/10.1136/jim-2017-000697.132 [abstract] -USA
Rights and permissions
About this article
Cite this article
Pembrolizumab. Reactions Weekly 1696, 301 (2018). https://doi.org/10.1007/s40278-018-44489-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44489-1